Evaluating Computational Pathology Foundation Models for Prostate Cancer Grading under Distribution Shifts
Not on the map. Why?
Abstract (arXiv)
Pathology foundation models (PFMs) have emerged as powerful pretrained encoders for computational pathology, but their robustness under clinically relevant distribution shifts remains insufficiently understood. We benchmark the robustness of recent PFMs in the setting of prostate cancer grading from whole-slide images (WSIs). Using the PANDA dataset, we evaluate PFMs as frozen patch-level feature extractors within weakly supervised slide-level grading models, and assess robustness to two important forms of distribution shift: shifts in WSI image appearance across collection sites, and shifts in the label distribution over cancer grade groups. Across in-distribution settings, PFMs consistently achieve strong performance and clearly outperform a natural-image baseline. Under cross-site transfer from Radboud to Karolinska, however, performance drops substantially for all models, showing that large-scale pretraining alone does not guarantee robust downstream generalization. In contrast, PFMs are less sensitive to label-distribution shift, indicating that visually grounded domain shift is the dominant challenge. Representation analysis further supports these findings by revealing persistent domain separation between sites across all PFMs. While grade-related structure is present, it is comparatively weak, indicating that domain-related variation dominates in the learned feature space. Together, these results provide a comprehensive benchmark of PFMs under distribution shift and highlight an important practical message: although PFMs provide strong representations, generalizability remains constrained by the quality and diversity of the data used to train downstream prediction models.
Key facts. Cited by 9 papers in the map (data through 14 Oct 2026). Builds on 25 of its 66 references that are in the map. First posted on arXiv 9 Oct 2024.
Builds on
25 of 66 references.
References · 25
- 2015Deep Residual Learning for Image Recognitioncited by 52,096
- 2020An Image is Worth 16x16 Words: Transformers for Image Recognition at Scalecited by 30,186
- 2014ImageNet Large Scale Visual Recognition Challengecited by 8,498
- 2023DINOv2: Learning Robust Visual Features without Supervisioncited by 7,974
- 2021On the Opportunities and Risks of Foundation Modelscited by 4,033
- 2018UMAP: Uniform Manifold Approximation and Projection for Dimension Reductioncited by 2,898
- 2019Benchmarking Neural Network Robustness to Common Corruptions and Perturbationscited by 2,877
- 2020WILDS: A Benchmark of in-the-Wild Distribution Shiftscited by 1,375
- 2019Can You Trust Your Model's Uncertainty? Evaluating Predictive Uncertainty Under Dataset Shiftcited by 1,287
- 2022CoCa: Contrastive Captioners are Image-Text Foundation Modelscited by 1,274
- 2018Attention-based Deep Multiple Instance Learningcited by 1,095
- 2020Data Efficient and Weakly Supervised Computational Pathology on Whole Slide Imagescited by 745
13 more
- 2024Virchow2: Scaling Self-Supervised Mixed Magnification Models in Pathologycited by 161
- 2023Foundational Models in Medical Imaging: A Comprehensive Survey and Future Visioncited by 76
- 2024Phikon-v2, A large and public feature extractor for biomarker predictioncited by 74
- 2024A Clinical Benchmark of Public Self-Supervised Pathology Foundation Modelscited by 66
- 2024Hibou: A Family of Foundational Vision Transformers for Pathologycited by 57
- 2024Benchmarking foundation models as feature extractors for weakly-supervised computational pathologycited by 49
- 2023Domain Generalization in Computational Pathology: Survey and Guidelinescited by 29
- 2024Towards Large-Scale Training of Pathology Foundation Modelscited by 23
- 2020Predicting molecular phenotypes from histopathology images: a transcriptome-wide expression-morphology analysis in breast cancercited by 21
- 2023How Reliable is Your Regression Model's Uncertainty Under Real-World Distribution Shifts?cited by 14
- 2024A Comprehensive Evaluation of Histopathology Foundation Models for Ovarian Cancer Subtype Classificationcited by 13
- 2021Transcriptome-wide prediction of prostate cancer gene expression from histopathology images using co-expression based convolutional neural networkscited by 9
- 2023Benchmarking Pathology Feature Extractors for Whole Slide Image Classificationcited by 9
Built on by
Citing papers per year: 2025: 4; 2026: 5.
9 papers.
- 2025PathBench: A comprehensive comparison benchmark for pathology foundation models towards precision oncologycited by 24
- 2026Atlas 2 -- Foundation models for clinical deploymentcited by 7
- 2025TICON: A Slide-Level Tile Contextualizer for Histopathology Representation Learningcited by 6
- 2025Beyond Diagnostic Performance: Revealing and Quantifying Ethical Risks in Pathology Foundation Modelscited by 4
- 2025Graph Laplacian Transformer with Progressive Sampling for Prostate Cancer Gradingcited by 0
- 2026From Patches to Patients: A study of the tile-to-slide performance transferability in Digital Pathologycited by 0
- 2026Robustifying pathology foundation models via fine-tuningcited by 0
- 2026HERO: Histology Encoder for Robust Representation in Oncologycited by 0
- 2026Scaling Multi-Teacher Distillation for Digital Pathologycited by 0
- 2026Scaling Multi-Teacher Distillation for Digital Pathology8 Oct 2026
- 2026HERO: Histology Encoder for Robust Representation in Oncology28 Sep 2026
- 2026Robustifying pathology foundation models via fine-tuning24 Jul 2026
- 2026From Patches to Patients: A study of the tile-to-slide performance transferability in Digital Pathology9 Jun 2026
- 2026Atlas 2 -- Foundation models for clinical deployment8 Jan 2026
- 2025TICON: A Slide-Level Tile Contextualizer for Histopathology Representation Learning24 Dec 2025
- 2025Graph Laplacian Transformer with Progressive Sampling for Prostate Cancer Grading11 Dec 2025
- 2025PathBench: A comprehensive comparison benchmark for pathology foundation models towards precision oncology26 May 2025
- 2025Beyond Diagnostic Performance: Revealing and Quantifying Ethical Risks in Pathology Foundation Models24 Feb 2025